Dear DOEX Users,
DOEX will list LDO/USDT、JTO/USDT、SUI/USDT spot trading pair, with the schedule as follows:
- Deposit Time: September 4, 2024, 15:00 (UTC+8)
- Trading Time: September 5, 2024, 15:00 (UTC+8)
- Withdrawal Time: September 6, 2024, 15:00 (UTC+8)
Spot Trading Link: LDO/USDT、JTO/USDT、SUI/USDT
LDO Overview
Lido DAO is a decentralized autonomous organization (DAO) which provides staking infrastructure for multiple blockchain networks.The platform’s native token is LDO - which also serves as the governance token for Lido DAO.
Contract Address: :https://etherscan.io/token/0x5a98fcbea516cf06857215779fd812ca3bef1b32
JTO Overview
Jito Network is a major contributor to the Solana ecosystem through its JitoSOL liquid staking pool, and its collection of MEV products.
Users can exchange their SOL for JitoSOL. In return, holders maintain SOL’s liquidity and DeFi opportunities while earning yield from staking. JitoSOL uniquely provides its holders with additional rewards from transaction revenue associated with MEV extraction on Solana.
Contract Address: https://solana.fm/address/jtojtomepa8beP8AuQc6eXt5FriJwfFMwQx2v2f9mCL?cluster=mainnet-alpha
SUI Overview
Sui is a groundbreaking layer-1 blockchain platform designed to support the needs of global adoption by offering a secure, powerful, and scalable development platform.Through innovations like zkLogin, sponsored transactions, and programmable transaction blocks, Sui creates a higher standard for user experience within Web3 by ensuring applications are accessible and user-friendly.
Contract Address: https://suiscan.xyz/mainnet/coin/0x2::sui::SUI/txs
[Risk Warning] The crypto market/activity is inherently risky, and digital investment decisions should be made with caution. We advise users to carefully consider and evaluate their investment capacity and risk tolerance.
DOEX will continue to provide you with improved products and superior services.
DOEX Team
September 3, 2024
Follow us on
X | Telegram | YouTube | Instagram | Medium
ข้อคิดเห็น
0 ข้อคิดเห็น
บทความนี้ถูกปิดการแสดงข้อคิดเห็น